« Previous
Next »
Cancer Letters
Volume 297, Issue 1
, Pages 1-8
, 1 November 2010
Curcumin causes superoxide anion production and p53-independent apoptosis in human colon cancer cells
References
- . Cancer statistics 2009. CA Cancer J. Clin. 2009;59:225–249
- . Evolving treatment of advanced colon cancer. Annu. Rev. Med. 2009;60:207–219
- . Dietary polyphenolic phytochemicals – promising cancer chemopreventative agents in humans? A review of their clinical properties. Int. J. Cancer. 2007;120:451–458
- . Curcumin: the Indian solid gold. Adv. Exp. Med. Biol. 2007;1–75
- . Curcumin as “Curecumin”: from kitchen to clinic. Biochem. Pharmacol. 2008;75:787–809
- . Curcumin modifies Apcmin apoptosis resistance and inhibits 2-amino 1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) induced tumour formation in Apcmin mice. Carcinogenesis. 2001;22:821–825
- . Plant phenolics decrease intestinal tumors in an animal model of familial adenomatous polyposis. Carcinogenesis. 2000;21:921–927
- . Inhibition of 7,12-dimethylbenz[a]anthracene (DMBA)-induced oral carcinogenesis in hamsters by tea and curcumin. Carcinogenesis. 2002;23:1307–1313
- . Curcumin induces the degradation of cyclin E expression through ubiquitin-dependent pathway and up-regulates cyclin-dependent kinase inhibitors p21 and p27 in multiple human tumor cell lines. Biochem. Pharmacol. 2007;73:1024–1032
- . Curcumin inhibits human colon cancer cell growth by suppressing gene expression of epidermal growth factor receptor through reducing the activity of the transcription factor Egr-1. Oncogene. 2006;25:278–287
- . Curcumin-induced apoptosis in ovarian carcinoma cells is p53-independent and involves p38 mitogen-activated protein kinae activation and downregulation of Bcl-2 and survivin expression and Akt signaling. Mol. Carcinog. 2010;49:13–24
- . Effect of curcumin on normal and tumor cells: role of glutathione and bcl-2. Mol. Cancer Ther. 2004;3:1101–1108
- . Mitochondrial reactive oxygen species affect sensitivity to curcumin-induced apoptosis. Free Radic. Biol. Med. 2008;44:1382–1393
- . Curcumin: preventive and therapeutic properties in laboratory studies and clinical trials. Antioxid. Redox. Signal. 2008;10:511–545
- . p53 mutation heterogeneity in cancer. Biochem. Biophys. Res. Commun. 2005;331:834–842
- . Suppressor gene alterations in the colorectal adeno-carcinoma sequence. J. Cell. Biochem. Suppl. 1992;16G:137–141
- . Surfing the p53 network. Nature. 2000;408:307–310
- . Curcumin induces a p53-dependent apoptosis in human basal cell carcinoma cells. J. Invest. Dermatol. 1998;111:656–661
- . Curcumin induces apoptosis in human breast cancer cells through p53-dependent Bax induction. FEBS Lett. 2002;512:334–340
- . Curcumin selectively induces apoptosis in deregulated cyclin D1-expressed cells at G2 phase of cell cycle in a p53-dependent manner. J. Biol. Chem. 2005;280:20059–20068
- . Induction of apoptosis in human lung cancer cells by curcumin. Cancer Lett. 2004;208:63–170
- . p53 mutations in colorectal cancer. Proc. Natl. Acad. Sci. USA. 1990;87:7555–7559
- . Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science. 1998;282:1497–1501
- . Curcumin induces apoptosis in HCT-116 human colon cancer cells in a p21-independent manner. Exp. Mol. Pathol. 2008;84:230–233
- . Nuclear apoptotic changes: an overview. J. Cell. Biochem. 2001;82:634–646
- . A quantitative nitroblue tetrazolium assay for determining intracellular superoxide anion production in phagocytic cells. J. Immunoassay Immunochem. 2006;27:31–44
- . Caspases: the executioners of apoptosis. Biochem. J. 1997;326:1–16
- . Molecular mechanism of curcumin induced cytotoxicity in human cervical carcinoma cells. Mol. Cell. Biochem. 2009;325:107–119
- . Curcumin induces caspase-3-dependent apoptotic pathway but inhibits DNA fragmentation factor 40/caspase-activated DNase endonuclease in human Jurkat cells. Mol. Cancer Ther. 2006;5:927–934
- . Clinical implications of p53 mutations. Cell. Mol. Life Sci. 1999;55:64–75
- . Curcumin impairs tumor suppressor p53 function in colon cancer cells. Carcinogenesis. 2004;25:1611–1617
- . Negative regulation of β4 integrin transcription by homeodomain-interacting protein kinase 2 and p53 impairs tumor progression. Cancer Res. 2009;69:5978–5986
- . Induction of p21 by p65 in p53 null cells treated with Doxorubicin. Biochim. Biophys. Acta. 2008;1783:935–940
- . Curcumin-induced apoptosis of human colon cancer Colo 205 cells through the production of ROS, Ca2+ and the activation of caspase-3. Anticancer Res. 2006;26:4379–4389
- . Oxidative stress and apoptosis: impact on cancer therapy. J. Pharm. Sci. 2007;96:2181–2196
- . Mechanism of cell death induced by cis-3,4′,5-trimethoxy-3′-aminostilbene in ovarian cancer. Gynecol. Oncol. 2008;110:110–117
- . Mitogen-activated protein kinases in apoptosis regulation. Oncogene. 2004;23:2838–2849
- . The chemopreventative agent curcumin is a potent radiosensitizer of human cervical tumor cells via increased reactive oxygen species production and overactivation of the mitogen-activated protein kinase pathway. Mol. Pharmacol. 2008;73:1491–1501
PII: S0304-3835(10)00233-8
doi: 10.1016/j.canlet.2010.04.018
© 2010 Elsevier Ireland Ltd. All rights reserved.
« Previous
Next »
Cancer Letters
Volume 297, Issue 1
, Pages 1-8
, 1 November 2010
